{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:11:36Z","timestamp":1748059896507},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,4]]},"DOI":"10.7759\/cureus.38536","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T13:14:05Z","timestamp":1683206045000},"source":"Crossref","is-referenced-by-count":3,"title":["The Liver-Heart Connection: A Literature Review of Liver Disease as a Risk Factor for Atrial Fibrillation"],"prefix":"10.7759","author":[{"given":"Mukosolu F","family":"Obi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Reinberg Palmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikhyath","family":"Namireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick N","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Joon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman SL","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008, 134:1655-69. 10.1053\/j.gastro.2008.03.003","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman SL","year":"2010","unstructured":"Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010, 7:425-36. 10.1038\/nrgastro.2010.97","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2020.61.10.860","article-title":"Association between atrial fibrillation and advanced liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"61","author":"Kang MK","year":"2020","unstructured":"Kang MK, Park JG, Kim MC. Association between atrial fibrillation and advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Yonsei Med J. 2020, 61:860-7. 10.3349\/ymj.2020.61.10.860","journal-title":"Yonsei Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2017.08.001","article-title":"The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis","volume":"41","author":"Wijarnpreecha K","year":"2017","unstructured":"Wijarnpreecha K, Boonpheng B, Thongprayoon C, Jaruvongvanich V, Ungprasert P. The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis. Clin Res Hepatol Gastroenterol. 2017, 41:525-32. 10.1016\/j.clinre.2017.08.001","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.957245","article-title":"High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation","volume":"13","author":"Decoin R","year":"2022","unstructured":"Decoin R, Butruille L, Defrancq T, et al.. High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation. Front Endocrinol (Lausanne). 2022, 13:957245. 10.3389\/fendo.2022.957245","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2020.0550","article-title":"Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions","volume":"33","author":"Haghbin H","year":"2020","unstructured":"Haghbin H, Gangwani MK, Ravi SJ, et al.. Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions. Ann Gastroenterol. 2020, 33:603-14. 10.20524\/aog.2020.0550","journal-title":"Ann Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13126","article-title":"The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature","volume":"36","author":"Di Stefano C","year":"2016","unstructured":"Di Stefano C, Milazzo V, Milan A, Veglio F, Maule S. The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature. Liver Int. 2016, 36:1081-9. 10.1111\/liv.13126","journal-title":"Liver Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2012.02449","article-title":"Inducibility of atrial fibrillation after GP ablations and \"autonomic blockade\": evidence for the pathophysiological role of the nonadrenergic and noncholinergic neurotransmitters","volume":"24","author":"Liu Y","year":"2013","unstructured":"Liu Y, Scherlag BJ, Fan Y, et al.. Inducibility of atrial fibrillation after GP ablations and \"autonomic blockade\": evidence for the pathophysiological role of the nonadrenergic and noncholinergic neurotransmitters. J Cardiovasc Electrophysiol. 2013, 24:188-95. 10.1111\/j.1540-8167.2012.02449","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.03.003","article-title":"Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation","volume":"12","author":"Xi Y","year":"2015","unstructured":"Xi Y, James Chao ZY, Yan W, et al.. Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation. Heart Rhythm. 2015, 12:1352-61. 10.1016\/j.hrthm.2015.03.003","journal-title":"Heart Rhythm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000518","article-title":"Ionic mechanisms underlying the effects of vasoactive intestinal polypeptide on canine atrial myocardium","volume":"6","author":"Xi Y","year":"2013","unstructured":"Xi Y, Wu G, Ai T, et al.. Ionic mechanisms underlying the effects of vasoactive intestinal polypeptide on canine atrial myocardium. Circ Arrhythm Electrophysiol. 2013, 6:976-83. 10.1161\/CIRCEP.113.000518","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber KT","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013, 10:15-26. 10.1038\/nrcardio.2012.158","journal-title":"Nat Rev Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","author":"Ho JE","year":"2014","unstructured":"Ho JE, Yin X, Levy D, et al.. Galectin 3 and incident atrial fibrillation in the community. Am Heart J. 2014, 167:729-34.e1. 10.1016\/j.ahj.2014.02.009","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2015.04.021","article-title":"Galectin-3 in atrial fibrillation: simple bystander, player or both?","volume":"48","author":"Lippi G","year":"2015","unstructured":"Lippi G, Cervellin G, Sanchis-Gomar F. Galectin-3 in atrial fibrillation: simple bystander, player or both?. Clin Biochem. 2015, 48:818-22. 10.1016\/j.clinbiochem.2015.04.021","journal-title":"Clin Biochem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.05.030","article-title":"Liver stiffness not fatty liver disease is associated with atrial fibrillation: the Rotterdam study","volume":"77","author":"van Kleef LA","year":"2022","unstructured":"van Kleef LA, Lu Z, Ikram MA, de Groot NM, Kavousi M, de Knegt RJ. Liver stiffness not fatty liver disease is associated with atrial fibrillation: the Rotterdam study. J Hepatol. 2022, 77:931-8. 10.1016\/j.jhep.2022.05.030","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14087","article-title":"Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction","volume":"9","author":"Liu X","year":"2022","unstructured":"Liu X, Chen W, Shao W, et al.. Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction. ESC Heart Fail. 2022, 9:3985-94. 10.1002\/ehf2.14087","journal-title":"ESC Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1245","article-title":"Role of galectin-3 in the pathogenesis and progression of biliary atresia","volume":"20","author":"Yoeli D","year":"2022","unstructured":"Yoeli D, Mack CL, Navarro-Alvarez N. Role of galectin-3 in the pathogenesis and progression of biliary atresia. Clin Liver Dis (Hoboken). 2022, 20:170-4. 10.1002\/cld.1245","journal-title":"Clin Liver Dis (Hoboken)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/154993-the-liver-heart-connection-a-literature-review-of-liver-disease-as-a-risk-factor-for-atrial-fibrillation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:04Z","timestamp":1707508684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/154993-the-liver-heart-connection-a-literature-review-of-liver-disease-as-a-risk-factor-for-atrial-fibrillation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.38536","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,4]]}}}